Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

What Is Renal Cell Carcinoma? It's the most common type of kidney cancer. Although it’s a serious disease, finding and treating it early makes it more likely that you’ll be cured. No matter ...

An expert discusses how third line (3L) systemic therapy for metastatic renal cell carcinoma (mRCC) is guided by prior ...

Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, ...

Count Me In, a patient-partnered research initiative led by the Broad Institute of MIT and Harvard and Dana-Farber Cancer ...

By that time, Berry was diagnosed with metastatic renal cell carcinoma, a kidney cancer that had spread to other parts of her ...

Renal cell carcinoma highlights from ASCO GU 2025 include follow-up data from the CheckMate 9ER study, updated COSMIC-313 results, and promising early data on casdatifan, a new HIF-2 alpha inhibitor.

A Duluth teenager with terminal cancer celebrated her birthday and high school graduation early this month with a ...

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

Count Me In, a patient-partnered research initiative led by Dana-Farber Cancer Institute and the Broad Institute of MIT and ...

A study identified a link between sex hormones and renal cell carcinoma, suggesting potential new treatment strategies.

US-based biotechnology company Inceptor Bio has dosed the first subject in the investigator-initiated trial of its lead ...